info@ehidc.org

 202-624-3270

Access And Actionability Are Key For Genetic Testing And Precision Medicine

Analytics

  • Analytics

    Examine how healthcare data can provide insight across claims, cost, clinical, and more.

Access And Actionability Are Key For Genetic Testing And Precision Medicine

January 15, 2020

Access And Actionability Are Key For Genetic Testing And Precision Medicine

Over the past two decades, the field of medical genomics underwent nothing less than a revolution in terms of both technological advancement and accumulated knowledge. This revolution holds the promise of changing the entire medical practice, and while the industry continues to improve genome sequencing technologies and decrease the price of sequencing a genome, other challenges are lurking that hinder the prospects of this revolution and undermine the efforts of wide-scale integration of genomics into mainstream medicine.

The full Forbes article can be viewed at this link.  

 

Share